![]()
产品详情
产品名称 英文名称:(3S,4S)-Tofacitinib 同义词 1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3S,4S)-、3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile、CS-1108、NCGC00348153-01、racemic-Tasocitinib、(3S,4S)-托法替尼 产品性质 CAS编号:1092578-47-6 分子式:C16H20N6O 分子量:312.37 PubChem编号:20111936 别名:(3S,4S)-托法替尼 英文别名:1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3S,4S)-|3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile|CS-1108|NCGC00348153-01|racemic-Tasocitinib| 规格或纯度:96% 英文名称:(3S,4S)-Tofacitinib 生化机理:Tasocitinib also known as CP690550 is an JAK kinase inhibitor. An IC50 estimated at 0.2 μM for PV patient progenitor cells. 储存温度:-20°C储存 运输条件:超低温冰袋运输 产品介绍:Tofacitinib是高效JAK3抑制剂,IC50为1 nM,比对JAK2和JAK1的抑制性高20倍和100倍。Tofacitinib is a novel inhibitor of JAK3 with IC50 of 1 nM, 20- to 100-fold less potent against JAK2 and JAK1. PubChem SID:488199775 IUPAC Name:3-[(3S,4S)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile INCHI:InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m0/s1 InChi Key:UJLAWZDWDVHWOW-WCQYABFASA-N Canonical SMILES:CC1CCN(CC1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N Isomeric SMILES:C[C@H]1CCN(C[C@H]1N(C)C2=NC=NC3=C2C=CN3)C(=O)CC#N PubChem CID:20111936 溶解性:DMSO 100 mg/mL Ethanol 100 mg/mL 产品包装
免责声明:以上所展示的信息由企业自行提供,内容的真实性
、准确性和合法性由发布企业负责,chemdig对此不承担任何保证责任。 同时我们郑重提醒各位买/卖家,
交易前 请详细核实对方身份,切勿随意打款或发货,谨防上当受骗。如发现虚假信息,请向chemdig举报。 |
上海阿拉丁生化科技股份有限公司
|
上海阿拉丁生化科技股份有限公司
邮箱 | market@aladdin-e.com |
联系人 | 18521732826 |
咨询请告知是在ChemDig上看到的,有助于交易达成。